Vaccine Therapy in Treating Patients With Metastatic Solid Tumors

NCT01376505
Breast cancer type: HER2+
Recruitment status: Recruiting
Phase 1
Interventions: Biological: HER-2 vaccine|Biological: Extension HER-2 vaccine trial at OBD
Drug category:

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Senior)
Location of metastases:
Additional Notes: The experimental arm of this study has completed, but the extension arm is still recruiting
Exclusions:
https://ClinicalTrials.gov/show/NCT01376505

Comments are closed.

Up ↑